Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
nCorxel is a specialized contract research organization (CRO) that provides comprehensive clinical development services to the biotechnology and pharmaceutical industries. The company focuses on accelerating the transition of innovative therapies from preclinical stages through late-phase clinical trials, with a particular emphasis on the Asia-Pacific and North American markets. nCorxel offers a suite of services including clinical trial management, regulatory affairs consulting, medical writing, and data management. By leveraging its expertise in complex therapeutic areas such as oncology and cell therapy, nCorxel aims to streamline the drug development process for its global partners. The company is positioned as a strategic partner for emerging biotech firms seeking to navigate the regulatory landscapes of multiple regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on nCorxel.